Neha Periwal PhD.

Researcher at Vgenomics. During her time at Jamia Hamdard, she gained exposure in both applying machine learning as well as deep learning techniques which can be applied to parse datasets in multiple omics fields.

Post Template FInal

The lorem ipsum text is boring here is a sentence instead! Excerpt should be max 2 sentences.

Why plasma cells?

This is a drawing of a plasma cell. Plasma cells are B cells that are secreting soluble antibodies. When an antigen is presented to a naive B cell, the cell responds by dividing rapidly. Naive B cells differentiate into plasma cells and memory B cells

Posting Template

Home Learn You are here ⬤ Catchy Heading wow can’t believe it! And the excerpt! Thumbnail Whoa subsection! Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem […]

Locations

Quick Links

Social

Linkedin Instagram Youtube Facebook

Copyright © 2023 Vgenomics | All rights reserved

With a decade of diverse experience under his belt, Sameer Malik, an alumnus of the Delhi School of Economics, brings a robust blend of business strategy, finance, operations, and sales expertise to Vgenomics. From kick starting his career at KPMG to founding and scaling an e-commerce startup to over $1.5 million in annual revenues, and further contributing to the startup ecosystem through his involvement in Startup Nexus and Token Amigo, Sameer has navigated through various industries, consistently playing to his strategic and operational strengths. His rich entrepreneurial journey and strategic acumen are now channeled towards advancing Vgenomics' mission in the realm of rare inborn diseases diagnostics and therapeutic solutions.

A translational biologist based in Silicon Valley, Dr. Lal brings her expertise in data science, translational medicine, clinical biomarker, and CDx implementation across all phases of clinical trials development to Vgenomics. With over 150 patents to her name, she has substantial experience in regulatory interactions with both the drug and device divisions of the FDA, and companion diagnostics (Dx) programs.

After earning her doctorate from International Center of Genetic Engineering and Biotechnology (ICGEB), Dr. Sardar embarked on a mission to transform her research findings into practical applications that could benefit rare disease patients globally. She noticed a gap in dedicated solutions for the burgeoning hub of rare diseases in India, particularly those affecting children, and co-founded Vgenomics with Dr. Preeti to develop affordable diagnostics and therapeutic solutions.

Open chat
✉ Hey! Need Help?
Hello
Can we help you?